Or Yat Sun
Insider CIK 1571212 · ENTA Sr. VP, R&D & CSO, 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2026-02-12 | 2026-02-13 | 3,413 | $14.25 | $48.6K | 374,854 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 1,650 | — | $0 | 373,042 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2026-02-12 | 2026-02-13 | 5,225 | — | $0 | 378,267 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2025-12-05 | 2025-12-05 | 2,390 | $14.23 | $34.0K | 371,392 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2025-12-01 | 2025-12-03 | 753 | $14.12 | $10.6K | 373,782 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2025-11-25 | 2025-11-26 | 110,000 | — | $0 | 110,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2025-02-12 | 2025-02-14 | 9,750 | — | $0 | 378,859 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2025-02-12 | 2025-02-14 | 4,324 | $5.59 | $24.2K | 374,535 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2024-12-06 | 2024-12-10 | 2,591 | $8.06 | $20.9K | 369,109 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2024-12-01 | 2024-12-03 | 1,595 | $8.60 | $13.7K | 371,700 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2024-11-27 | 2024-11-27 | 87,000 | — | $0 | 87,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2024-02-12 | 2024-02-14 | 1,080 | $12.41 | $13.4K | 373,295 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2024-02-12 | 2024-02-14 | 3,680 | — | $0 | 374,375 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2023-12-05 | 2023-12-06 | 2,412 | $9.63 | $23.2K | 370,695 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2023-12-01 | 2023-12-05 | 1,595 | $9.49 | $15.1K | 373,107 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2023-11-22 | 2023-11-22 | 86,000 | — | $0 | 86,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2023-03-15 | 2023-03-17 | 13,925 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2023-03-15 | 2023-03-17 | 13,925 | $14.00 | $194.9K | 388,627 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2023-03-15 | 2023-03-17 | 269 | $43.92 | $11.8K | 388,358 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2023-03-15 | 2023-03-17 | 13,656 | $44.46 | $607.1K | 374,702 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2023-02-13 | 2023-02-15 | 10,250 | — | $0 | 369,437 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2023-02-13 | 2023-02-15 | 7,752 | $52.77 | $409.1K | 374,702 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2023-02-13 | 2023-02-15 | 13,017 | — | $0 | 382,454 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2022-12-01 | 2022-12-05 | 1,055 | $44.33 | $46.8K | 359,187 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2022-11-23 | 2022-11-28 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-11-23 | 2022-11-28 | 21,000 | — | $0 | 360,242 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2022-02-14 | 2022-02-15 | 953 | $62.49 | $59.6K | 339,242 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-02-14 | 2022-02-15 | 2,419 | — | $0 | 340,195 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2022-02-14 | 2022-02-15 | 615 | — | $0 | 337,776 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2021-12-01 | 2021-12-03 | 557 | $87.68 | $48.8K | 337,161 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2021-11-19 | 2021-11-23 | 28,400 | — | $0 | 28,400 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2021-11-19 | 2021-11-23 | 6,800 | — | $0 | 337,718 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-26 | 2021-01-28 | 5,149 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-26 | 2021-01-28 | 4,872 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2021-01-26 | 2021-01-28 | 3,672 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2021-01-26 | 2021-01-28 | 3,672 | $11.77 | $43.2K | 326,046 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2021-01-26 | 2021-01-28 | 4,872 | $11.77 | $57.3K | 330,918 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2021-01-26 | 2021-01-28 | 5,149 | $14.18 | $73.0K | 322,374 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2020-12-15 | 2020-12-16 | 5,250 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2020-12-15 | 2020-12-16 | 5,250 | — | $0 | 318,765 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2020-12-15 | 2020-12-16 | 1,540 | $42.52 | $65.5K | 317,225 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2020-11-20 | 2020-11-20 | 30,800 | — | $0 | 30,800 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2020-11-20 | 2020-11-20 | 7,600 | — | $0 | 313,515 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2020-02-12 | 2020-02-18 | 487 | — | $0 | 304,079 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2020-02-12 | 2020-02-18 | 1,089 | $52.76 | $57.5K | 305,915 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2020-02-12 | 2020-02-18 | 2,925 | — | $0 | 307,004 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-12-16 | 2020-01-06 | 5,250 | — | $0 | 5,250 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-12-16 | 2020-01-06 | 5,250 | — | $0 | 305,923 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2019-12-16 | 2020-01-06 | 2,331 | $63.88 | $148.9K | 303,592 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2019-11-18 | 2019-11-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-03-01 | 2019-03-04 | 5,910 | $103.32 | $610.6K | 304,763 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-03-01 | 2019-03-04 | 4,090 | $103.84 | $424.7K | 300,673 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2019-02-12 | 2019-02-13 | 4,500 | — | $0 | 306,416 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-12 | 2019-02-13 | 6,297 | $90.07 | $567.2K | 301,916 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2019-02-12 | 2019-02-13 | 6,993 | $88.88 | $621.5K | 310,673 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2019-02-12 | 2019-02-13 | 11,250 | — | $0 | 317,666 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-11 | 2019-02-13 | 8,772 | — | $0 | 5,149 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-11 | 2019-02-13 | 10,249 | — | $0 | 3,672 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2019-02-11 | 2019-02-13 | 6,956 | — | $0 | 13,926 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-11 | 2019-02-13 | 10,249 | $11.77 | $120.6K | 320,169 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-11 | 2019-02-13 | 6,956 | $14.00 | $97.4K | 327,125 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2019-02-11 | 2019-02-13 | 8,772 | $14.18 | $124.4K | 335,897 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 5,835 | $88.66 | $517.3K | 330,062 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 18,971 | $89.50 | $1.70M | 311,091 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 2,707 | $90.11 | $243.9K | 308,384 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2019-02-11 | 2019-02-13 | 171 | $91.24 | $15.6K | 308,213 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2018-11-16 | 2018-11-20 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2018-02-12 | 2018-02-13 | 2,666 | $76.85 | $204.9K | 309,920 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2018-02-12 | 2018-02-13 | 6,269 | — | $0 | 312,586 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2018-02-12 | 2018-02-13 | 2,600 | — | $0 | 306,317 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2017-11-17 | 2017-11-21 | 23,500 | — | $0 | 23,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2017-04-12 | 2017-04-14 | 6,963 | — | $0 | 6,963 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | F Tax w/h | 2017-02-13 | 2017-02-15 | 1,079 | $29.82 | $32.2K | 303,717 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award | 2017-02-13 | 2017-02-15 | 2,920 | — | $0 | 304,796 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2017-01-04 | 2017-01-05 | 13,921 | $35.09 | $488.5K | 301,876 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2016-11-29 | 2016-11-30 | 13,921 | $31.44 | $437.7K | 315,797 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-11-18 | 2016-11-22 | 35,000 | — | $0 | 35,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-11-18 | 2016-11-22 | 10,500 | — | $0 | 10,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-09-28 | 2016-09-29 | 3,478 | — | $0 | 3,478 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-07-20 | 2016-07-22 | 3,484 | — | $0 | 3,484 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-19 | 2016-01-20 | 5,800 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-19 | 2016-01-20 | 23,201 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-19 | 2016-01-20 | 13,921 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-19 | 2016-01-20 | 5,800 | $2.54 | $14.7K | 306,517 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-19 | 2016-01-20 | 23,201 | $2.54 | $58.9K | 329,718 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-19 | 2016-01-20 | 13,921 | $2.54 | $35.4K | 300,717 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2016-01-09 | 2016-01-11 | 3,478 | — | $0 | 3,478 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-04 | 2016-01-05 | 13,921 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-04 | 2016-01-05 | 13,921 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2016-01-04 | 2016-01-05 | 50,723 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-04 | 2016-01-05 | 13,921 | $1.51 | $21.0K | 286,796 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-04 | 2016-01-05 | 13,921 | $1.98 | $27.6K | 272,875 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2016-01-04 | 2016-01-05 | 50,723 | $2.97 | $150.6K | 258,954 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2015-11-20 | 2015-11-24 | 33,000 | — | $0 | 33,000 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-08-10 | 2015-08-11 | 2,150 | $42.57 | $91.5K | 209,831 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-08-10 | 2015-08-11 | 1,600 | $43.35 | $69.4K | 208,231 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-07-13 | 2015-07-14 | 630 | $46.56 | $29.3K | 211,981 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-07-13 | 2015-07-14 | 3,120 | $46.24 | $144.3K | 212,611 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-06-11 | 2015-06-15 | 3,750 | $42.47 | $159.3K | 215,731 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-06-05 | 2015-06-08 | 10,750 | $42.02 | $451.7K | 219,481 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2015-05-11 | 2015-05-12 | 8,000 | $36.13 | $289.0K | 230,231 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2015-01-06 | 2015-01-06 | 51,044 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2015-01-06 | 2015-01-06 | 6,960 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2015-01-06 | 2015-01-06 | 6,960 | $1.21 | $8.4K | 187,187 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2015-01-06 | 2015-01-06 | 51,044 | $1.21 | $61.8K | 238,231 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2014-11-20 | 2014-11-21 | 36,500 | — | $0 | 36,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-08-13 | 2014-08-15 | 100 | $40.04 | $4.0K | 180,227 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-08-13 | 2014-08-15 | 4,900 | $39.48 | $193.5K | 180,327 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2014-08-05 | 2014-08-06 | 11,149 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2014-08-05 | 2014-08-06 | 11,149 | $1.29 | $14.4K | 185,227 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-07-01 | 2014-07-03 | 4,700 | $42.20 | $198.3K | 174,378 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-07-01 | 2014-07-03 | 300 | $42.98 | $12.9K | 174,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-06-02 | 2014-06-04 | 3,799 | $37.38 | $142.0K | 180,279 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-06-02 | 2014-06-04 | 1,201 | $38.14 | $45.8K | 179,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-05-01 | 2014-05-02 | 1,301 | $36.29 | $47.2K | 187,777 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-05-01 | 2014-05-02 | 3,699 | $37.23 | $137.7K | 184,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-04-01 | 2014-04-02 | 8,200 | $38.92 | $319.1K | 190,878 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-04-01 | 2014-04-02 | 200 | $40.70 | $8.1K | 189,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-04-01 | 2014-04-02 | 1,600 | $40.22 | $64.4K | 189,278 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-03-24 | 2014-03-25 | 2,521 | $39.66 | $100.0K | 202,194 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-03-24 | 2014-03-25 | 4,363 | $38.42 | $167.6K | 204,715 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | S Sale | 2014-03-24 | 2014-03-25 | 3,116 | $40.36 | $125.8K | 199,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2014-01-10 | 2014-05-02 | 3,478 | — | $0 | 3,478 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2014-01-03 | 2014-01-13 | 7,250 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise deriv | 2014-01-03 | 2014-01-13 | 121,837 | — | $0 | 0 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2014-01-03 | 2014-01-13 | 7,250 | $0.73 | $5.3K | 209,078 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | M Exercise | 2014-01-03 | 2014-01-13 | 121,837 | $0.73 | $88.9K | 201,828 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2013-12-08 | 2013-12-09 | 12,500 | — | $0 | 12,500 | SEC↗ |
| ENTA ENANTA PHARMACEUTICALS INC | A Award deriv | 2013-12-05 | 2013-12-06 | 35,000 | — | $0 | 35,000 | SEC↗ |